Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Profit After Tax of $69.8 million for Q1 2026, up 215.83% year-on-year from $22.1 million in Q1 2025, and up 202.31% on a QoQ basis from -$68.2 million in Q4 2025.
Curaleaf Holdings (CURLF) Profit After Tax (2019 - 2026) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Profit After Tax for 8 consecutive years, with $69.8 million the latest figure, recorded in Q1 2026.
- Quarterly Profit After Tax rose 215.83% year-over-year to $69.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$103.6 million (up 52.99% YoY) and the FY2025 annual result came in at -$228.2 million, down 7.82% from the prior year.
- Profit After Tax climbed to $69.8 million in Q1 2026 per CURLF's latest filing, from -$68.2 million in the prior quarter.
- Over the last five years, Profit After Tax for CURLF reached as high as $69.8 million in Q1 2026 and fell as low as -$57.7 billion in Q4 2023.
- A 5-year average of -$3.4 billion and a median of -$51.6 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2023 — Profit After Tax slumped 21841.85% — and 2026, when it surged 215.83%.
- Year by year, Profit After Tax stood at -$262.7 million in 2022, then sank by 21841.85% to -$57.7 billion in 2023, then surged by 99.88% to -$67.2 million in 2024, then declined by 1.56% to -$68.2 million in 2025, then jumped by 202.31% to $69.8 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $69.8 million, -$68.2 million, and -$54.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | 69.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.78 Mn |
| Dec 31, 2025 | -68.21 Mn |
| Sep 30, 2025 | -54.55 Mn |
| Jun 30, 2025 | -50.60 Mn |
| Mar 31, 2025 | -60.25 Mn |
| Dec 31, 2024 | -67.17 Mn |
| Sep 30, 2024 | -44.35 Mn |
| Jun 30, 2024 | -48.55 Mn |
| Mar 31, 2024 | -51.58 Mn |
| Dec 31, 2023 | -57.65 Bn |
| Sep 30, 2023 | -67.81 Mn |
| Jun 30, 2023 | -66.59 Mn |
| Mar 31, 2023 | -43.88 Mn |
| Dec 31, 2022 | -262.75 Mn |
| Sep 30, 2022 | -41.42 Mn |
| Jun 30, 2022 | -17.26 Mn |
| Mar 31, 2022 | -21.76 Mn |
| Dec 31, 2021 | -75.50 Mn |
| Sep 30, 2021 | 57.67 Mn |
| Jun 30, 2021 | 8.28 Mn |